期刊文献+

乳腺癌组织中Cath-D、c-erbB-2的表达及其与肿瘤标志物水平、淋巴结转移的相关性 被引量:7

Relationship between Expression of Cath-D and c-erbB-2 and Lymph Node Metastasis in Breast Cancer
下载PDF
导出
摘要 目的观察乳腺癌患者病理组织中Cath-D、c-erbB-2的表达情况,并分析其与淋巴结转移、肿瘤标志物水平的相关性。方法选取接受手术治疗的乳腺癌患者为研究对象,同时选取同期接受手术治疗的乳腺纤维腺瘤患者为对照。观察乳腺癌(有、无淋巴转移组)、乳腺纤维腺瘤患者组织切片Cath-D、c-erbB-2阳性表达情况,比较乳腺癌(有、无淋巴转移组)、乳腺纤维腺瘤患者血清肿瘤标志物水平的差异,分析淋巴结转移的乳腺癌患者Cath-D、c-erbB-2阳性表达与肿瘤标志物水平的相关性。结果乳腺癌组患者的组织切片Cath-D、c-erbB-2阳性表达率均高于乳腺纤维腺瘤组(χ^(2)=51.796、70.090,P均<0.001);有淋巴结转移的乳腺癌患者组织切片Cath-D、c-erbB-2阳性表达率高于无淋巴结转移组。乳腺癌组患者血清CEA、CA15-3、CA125水平高于乳腺纤维腺瘤组(t=52.270、58.784、76.349,P<0.001);乳腺癌组有淋巴结转移组患者血清CEA、CA15-3、CA125水平高于无淋巴结转移组(t=16.681、27.880、23.216,P<0.001)。有淋巴结转移的乳腺癌患者Cath-D、c-erbB-2阳性表达率与血清CEA、CA15-3、CA125水平正相关。结论乳腺癌患者病理组织中Cath-D、c-erbB-2阳性表达率较高,且与淋巴结转移和肿瘤标志物水平相关。 Objective To observe the expression of Cath-D and c-erbB-2 in the pathological tissue of patients with breast cancer,and to analyze the correlation with lymph node metastasis and tumor marker level.Methods The breast cancer patients who received surgical treatment were selected as the research subjects.At the same time,the patients with breast fibroadenoma for the same period were selected as the control group.The positive expression of Cath-D and c-erbB-2 in tissue sections of breast cancer(with and without lymphatic metastasis)and breast fibroadenoma were observed.The difference of serum tumor markers in breast cancer(with and without lymph node metastasis)and breast fibroadenoma were compared.The positive expression of Cath-D and c-erbB-2 in breast cancer patients with lymphatic metastasis was analyzed.Correlation with the level of tumor markers.Results The positive rate of Cath-D and c-erbB-2 in breast cancer patients was higher than that of breast fibroadenoma(χ^(2)=51.796,70.090,P<0.001),and the positive rate of Cath-D and c-erbB-2 in the tissue section of breast cancer patients with lymph node metastasis was higher than that of the non lymph node metastasis group.The serum levels of CEA,CA15-3 and CA125 in breast cancer patients were higher than those in breast fibroadenoma group(t=52.270,58.784,76.349,P<0.001),and the serum levels of CEA,CA15-3 and CA125 in the patients with lymph node metastasis were higher than those without lymph node metastasis(t=16.681,27.880,23.216,P<0.001).The positive expression rates of Cath-D and c-erbB-2 in breast cancer patients with lymph node metastasis were positively correlated with serum CEA,CA15-3 and CA125 levels.Conclusion The positive expression rate of Cath-D and c-erbB-2 in breast cancer patients is high,and is correlated with lymph node metastasis and tumor marker level.
作者 齐小芬 白宾 薛会朝 王瑜 王国英 秦双 QI Xiaofen;BAI Bin;XUE Huizhao(First Affiliated Hospital of Xinxiang Medical College,Xinxiang,453100)
出处 《实用癌症杂志》 2021年第3期404-407,共4页 The Practical Journal of Cancer
基金 河南省科技厅科技攻关项目(编号:172102310405)。
关键词 乳腺癌 CATH-D C-ERBB-2 乳腺纤维腺瘤 肿瘤标志物 Breast cancer Cath-D c-erbB-2 Fibroadenoma of breast Tumor marker
  • 相关文献

参考文献10

二级参考文献49

  • 1侯景辉,曾敬,吴慧瑜,符珈,卢佳斌,吴秋良.表皮生长因子受体2和雌激素受体及孕激素受体在乳腺癌中的表达及相关性分析[J].中华临床医师杂志(电子版),2010,4(6):739-743. 被引量:5
  • 2王琰娟,米成嵘,王文.乳腺癌前哨淋巴结的超声造影检查及与乳腺癌组织ER、PR和HER-2表达的相关性[J].宁夏医科大学学报,2013,35(5):528-531. 被引量:8
  • 3陈玲,李旭,赵新汉.乳腺癌ER,PR,c-erbB-2表达与临床病理特征的相关性分析[J].第四军医大学学报,2006,27(17):1580-1583. 被引量:11
  • 4Amanda J. Harvey,Caroline J. Pennington,Sarah Porter,Rajpal S. Burmi,Dylan R. Edwards,William Court,Suzanne A. Eccles,Mark R. Crompton.Brk Protects Breast Cancer Cells from Autophagic Cell Death Induced by Loss of Anchorage[J]. The American Journal of Pathology . 2009 (3)
  • 5Berg M,Soreide K.EGFR and downstream genetic alterations in KRAS/BRAF and PI3K/AKT pathways in colorectalcancer:implications for targeted therapy[J].Discoy Med,2012,14(76):207-214.
  • 6Aka JA, Lin SX. Comparison of functional proteomic analyses of human breast cancer cell lines T47D and MCF7 [ J]. PLoS One, 2012, 7 (2) :31532.
  • 7Lee HR, Choi KC. 4-tert-Octylphenol stimulates the expression of ca- thepsins in human breast cancer ceils and xenografted breast tumors of a mouse model via an estrogen receptor-mediated signaling pathway[J]. Toxicology ,2013,304 : 13-20.
  • 8E1 MNT, Aboulella HA, Abul-Fadl AM, et al. Potential biomarkers tbr differentiation of benign prostatic hyperplasia and prostate cancer[ J ]. Br J Biomed Sci,2010,67 (3) : 109-112.
  • 9Szumilo J, Burdan F, Zinkiewicz K, et al. Expression of syndecan-1 and eathepsins D and K in advanced esophageal squamous cell carcinoma [J]. Folia Histoehem Cytobiol,2009,47(4) :571-578.
  • 10Hasan L, Mazzucehelli L, Liebi M, et al. Function of liver activa- tion-regulated chemokine/CC chemokine ligand 20 is differently affect- ed by eathepsin B and cathepsin D processing [ J ]. J Immunol,2006, 176 ( 11 ) :6512-6522.

共引文献50

同被引文献83

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部